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In vertebrates, ATM and ATR are critical regulators of
checkpoint responses to damaged and incompletely rep-
licated DNA. These checkpoint responses involve the
activation of signaling pathways that inhibit the repli-
cation of chromosomes with DNA lesions. In this study,
we describe the isolation of a cDNA encoding a full-
length version of Xenopus ATM. Using antibodies
against the regulatory domain of ATM, we have identi-
fied the essential replication protein Mcm2 as an ATM-
binding protein in Xenopus egg extracts. XenopusMcm2
underwent phosphorylation at Ser92 in response to the
presence of double-stranded DNA breaks or DNA repli-
cation blocks in egg extracts. This phosphorylation in-
volved both ATM and ATR, but the relative contribution
of each kinase depended upon the checkpoint-inducing
DNA signal. Furthermore, both ATM and ATR phospho-
rylated Mcm2 directly at Ser92 in cell-free kinase assays.
Immunodepletion of both ATM and ATR abrogated the
checkpoint response that blocks chromosomal DNA rep-
lication in egg extracts containing double-stranded DNA
breaks. These experiments indicate that ATM and ATR
phosphorylate the functionally critical replication pro-
tein Mcm2 during both DNA damage and replication
checkpoint responses in Xenopus egg extracts.
In eukaryotic cells, various checkpoint control mechanisms
guard the integrity of the genomic DNA throughout the cell
cycle (for reviews, see Refs. 1–3). For example, early in the cell
cycle, these regulatory pathways block the entry into S phase if
the genomic DNA suffers various types of damage. In cells that
already have entered S phase, other checkpoint responses act
to block further replication by inhibiting elongation at existing
forks and by preventing the firing of any new replication ori-
gins. Finally, the presence of damaged or incompletely repli-
cated DNA in the cell also prevents the entry into mitosis.
These pathways contain sensor proteins that detect various
nucleic acid structures and associated proteins at DNA repli-
cation forks or sites of DNA damage. The sensor proteins con-
trol the activity of effector proteins, which regulate cell cycle
processes. A third class of proteins termed mediators or adap-
tors may facilitate interactions between sensor and effector
proteins. Some checkpoint proteins may performmore than one
of these functions.
Members of the phosphoinositide kinase-related family of
protein kinases function at or near the top of various check-
point regulatory pathways. In vertebrates, the phosphoinosit-
ide kinase-related kinases include ATM and ATR (4). ATM
plays a key role in the response of cells to double-stranded DNA
breaks, which occur following ionizing radiation and other in-
sults to the genome. On the other hand, ATR is involved in
detecting DNA replication forks and any problems that might
arise in these critical but transient structures during S phase
(5–8). ATM is dispensable for cell viability, but absence of
functional ATR is lethal, presumably because of its role in
monitoring the success of DNA replication (9, 10). In view of the
importance of ATM and ATR to the preservation of genomic
integrity, it will be critical to elucidate how these kinases
undergo activation during checkpoint responses and to identify
their key downstream targets.
One of the important functions of checkpoint pathways reg-
ulated by the phosphoinositide kinase-related kinases appears
to be control of the DNA replication machinery in the cell (3).
The initiation of DNA replication is an elaborate process that
involves the sequential recruitment of key replication proteins
to future origins of DNA replication (11). Initially, the origin
recognition complex recruits Cdc6 and Cdt1 to the DNA. In
turn, these proteins allow the loading of the minichromosome
maintenance (MCM)1 complex onto the DNA. Thereafter, this
complex enables the binding of various additional proteins,
notably Cdc45, to chromatin. The binding of Cdc45 and regu-
lated phosphorylation by the kinases Cdc7 and Cdk2 are rate-
limiting steps for the initiation of DNA replication (12). The
MCM complex, possibly in conjunction with associated pro-
teins, appears to represent a specific helicase activity that is
essential for the replicative unwinding of DNA that begins at
newly fired origins. Not surprisingly, the MCM complex ap-
pears to be subject to multiple levels of regulation during the
cell cycle (reviewed in Refs. 13 and 14).
Xenopus egg extracts have proven to be a valuable tool for
functional analysis of checkpoint regulatory pathways. In this
system, the addition of the DNA polymerase inhibitor aphidi-
colin to elicit replication blocks results in the accumulation of
incompletely replicated DNA (15, 16). This response results in
the activation of Xchk1, the Xenopus homolog of the effector
kinase Chk1 (16). In this context, the activation of Xchk1
requires the action of Xenopus ATR (Xatr) (5, 6). Moreover,
DNA damage responses can also be studied in these extracts.
In particular, the introduction of DNA with free double-
stranded ends, which would mimic damaged DNA, into these
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extracts inhibits both DNA replication and entry into mitosis
(17–19). As is the case in human cells, ATM is involved in
checkpoint regulation in response to the presence of DNA with
exposed double-stranded ends (18).
For this study, we set out to probe the function and regula-
tion of ATM by searching for ATM-interacting proteins in Xe-
nopus egg extracts. To initiate these experiments, we isolated a
cDNA encoding the full-length version of Xenopus ATM (Xatm).
Using antibodies against a previously undescribed region from
the regulatory domain of Xatm, we identified Xenopus Mcm2
(Xmcm2) as a specific binding partner for Xatm. Moreover, we
also found that Xmcm2 is a direct and efficient substrate of
ATM. Further analyses indicated that Xmcm2 is likewise a
specific target of ATR. Therefore, Xmcm2 is a direct target of
the two major phosphoinositide kinase-related kinases in-
volved in DNA-regulated checkpoint responses in this system.
EXPERIMENTAL PROCEDURES
Cloning of a cDNA Encoding Full-length Xatm—Poly(A) RNA was
isolated from Xenopus oocyte total RNA and subjected to first strand
cDNA synthesis. A Xenopus oocyte cDNA library was constructed and
ligated with adaptors using the Marathon cDNA amplification kit
(Clontech). 5-Rapid amplification of cDNA ends/PCR was performed
using primer 5-TGCCCACAATGACATGGTGGTGACACTC-3 based
on a sequence in the C-terminal half of Xatm and adaptor primer-1 from
the Marathon cDNA kit. After a second PCR using nested primers
(5-GCAACAGATCGAGGCAAAGCAAGAGACTG-3 and adaptor prim-
er-2 from the Marathon cDNA kit), a 4.6-kb PCR product that encodes
the N-terminal half of Xatm was obtained. A 9.2-kb fragment was
amplified from the same library using two oligonucleotides (5-AT-
GAGTCTTGCGCTACATGAGCTGCTGCTCTGC-3 and 5-GCAGAG-
CAGCAGCTCATGTAGCGCAAGACTCAT-3) that were designed to
span the full-length coding sequence of Xatm. Sequencing of both DNA
strands from this fragment revealed an open reading frame of 3061
amino acids.
Antibodies—A DNA fragment encoding amino acids 634–878 of
Xatm was produced by PCR and cloned into a pET-His6 expression
vector. The His6-Xatm-(634–878) protein was expressed in Escherichia
coli, isolated on nickel-agarose, and used for production of antibodies at
a commercial facility. These antibodies recognized the 350-kDa Xatm
protein in Xenopus egg extracts by both immunoprecipitation and im-
munoblotting. An anti-human BM28 monoclonal antibody, which rec-
ognizes Xmcm2, was purchased from Cell Signaling Technology. Con-
trol rabbit IgG was obtained from Zymed Laboratories Inc.. For anti-
phospho-Ser92 antibodies against phosphorylated Xmcm2, the peptide
CEDLTASQREAA (containing residues 87–97) was synthesized with a
phosphate at Ser92 and an extra cysteine residue for conjugation to
keyhole limpet hemocyanin. Anti-phosphopeptide antibodies were pre-
pared as described (20). Affinity-purified antibodies against Xatr,
Xchk2, Xchk1, and Xorc2 were as described previously (16, 17, 21, 22).
Antisera against Xmcm4 and Xmcm7 were the generous gift of Dr. J. J.
Blow (University of Dundee) (23).
Xenopus Egg Extracts—Xenopus egg extracts were prepared as de-
scribed (21). Extracts were treated with 50 g/ml (dA)70-(dT)70 to induce
checkpoint responses as described (21). To prepare extracts containing
chromatin with double-stranded DNA breaks or DNA replication
blocks, demembranated sperm nuclei (1000–3000/l) were incubated in
extracts containing 0.05 unit/l EcoRI or 100 g/ml aphidicolin, respec-
tively. Caffeine was added at a final concentration of 5 mM to override
checkpoint responses (5, 16).
Immunoprecipitation and Immunodepletion—For immunoprecipita-
tions, extracts (100 l) were incubated with protein A-conjugated mag-
netic beads (Dynal, Inc.) containing anti-Xatm antibodies (5 g) or with
protein G-conjugated magnetic beads containing anti-BM28 antibodies
(5 g) for 45 min at 4 °C. The beads were washed three times with 10
mM HEPES-KOH (pH 7.5), 150 mM NaCl, 0.5% Nonidet P-40, 2.5 mM
EGTA, and 20 mM -glycerol phosphate and once with HEPES-buffered
saline (10 mM HEPES-KOH (pH 7.5) and 150 mM NaCl) and subjected
to SDS-PAGE and immunoblotting. For immunodepletion of Xatm,
interphase extracts (100 l) were incubated with 30 g of anti-Xatm
antibodies bound to 120 l of protein A-conjugated magnetic beads at
4 °C for 45 min. The same amount of control rabbit IgG was used for
mock depletion. After the incubation, the beads were removed with a
magnet, and the supernatants were treated again for a second round of
depletion. Xatr was immunodepleted as described previously (24).
Identification of Xatm-interacting Proteins by Mass Spectrometry—
Anti-Xatm immunoprecipitates were subjected to SDS-PAGE and visu-
alized by staining with Coomassie Blue. Protein bands were excised, in
gel-digested with trypsin as described previously (25), and analyzed by
matrix-assisted laser desorption ionization mass spectrometry on an
AnchorChipTM 384–600 target as described (26). The peptide mass
fingerprint acquired from the digest of a band at 120 kDa identified the
Xenopus Mcm2 protein. Ten peptides were matched to its sequence
within better than 50 ppm mass tolerance, covering 12% of the protein
sequence. A data base search was performed against a non-redundant
protein data base (Mass Spectrometry Protein Sequence Database)
using Mascot software (Matrix Sciences Ltd., London, United
Kingdom). The protein score of the hit was 100 and exceeded the
threshold significance score of 74 (p  0.05); and therefore, the identi-
fication
was confident.
Kinase Assays—For kinase assays of endogenous Xatm, egg extracts
(50 l) were treated as indicated and then incubated with Affiprep-
protein A beads containing anti-Xatm antibodies (3 g) for 40 min at
4 °C with rotation. The same amount of rabbit IgG was used for control
samples. The beads were isolated and washed three times with 80 mM
-glycerol phosphate (pH 7.3), 20 mM EGTA, 15 mM MgCl2, and 1 mM
dithiothreitol and twice with HEPES-buffered saline. The beads were
resuspended in 50 l of HEPES-buffered saline. Aliquots (10 l) were
incubated with 1 g of PHAS-I or GST-Xmcm2 fragment as substrate at
room temperature. Wild-type and kinase-inactive versions of recombi-
nant human FLAG-tagged ATM and ATR were produced in 293T cells
and assayed for kinase activity as described (27).
Production of Recombinant Proteins in Insect Cells and Bacteria—
pFastBac vectors encoding Xmcm2 with GST and His6 tags at the
C-terminal end were derived from the pFastBac-Xchk1-GH vector (21).
His6-tagged versions of Xmcm2 were prepared in the pFastBacHT vec-
tor. Recombinant baculoviruses were generated with the Bac-to-Bac
system (Invitrogen). Recombinant baculovirus-expressed proteins were
produced in Sf9 insect cells and purified using nickel-agarose beads
(21). To prepare GST-tagged peptide fragments of Xmcm2, DNA frag-
ments encoding amino acids 62–122, 297–357, 485–545, and 757–817 of
Xmcm2 were cloned into a pGEX vector. GST-tagged proteins were
produced and purified from bacteria as described (28). Geminin was
prepared as described (29). Point mutants in Xmcm2 were produced
with the QuikChange kit (Stratagene).
Isolation of Nuclear and Chromatin Fractions—Egg extracts (100–
200 l) containing 3000 sperm nuclei/l were incubated under the
indicated conditions, overlaid on a 1-ml sucrose cushion containing
chromatin isolation buffer (20 mM HEPES-KOH (pH 7.6), 1 M sucrose,
80 mM KCl, 25 mM potassium gluconate, and 10 mM magnesium gluco-
nate), and centrifuged at 6100  g for 5 min. The pellets were washed
twice with chromatin isolation buffer. After centrifugation, the pellets
(nuclear fractions) were boiled in gel sample buffer and subjected to
SDS-PAGE. For preparation of chromatin fractions, the pellets were
washed once more with chromatin isolation buffer containing 0.5%
Nonidet P-40. The supernatant (nuclear soluble fraction) was removed,
and the chromatin pellets were processed for SDS-PAGE. To elute
proteins from nuclear fractions, nuclear pellets were incubated on ice
for 10 min with 10 mMHEPES-KOH (pH 7.6) containing 0.3 M NaCl and
0.5% Nonidet P-40. The samples were centrifuged at 11,700  g for 5
min, and the supernatants were subjected to immunoprecipitation.
Replication Assays—To monitor DNA replication, interphase ex-
tracts were incubated with 1000–3000 sperm nuclei/l and 100 g/ml
cycloheximide in the presence of [-32P]dATP as described (24).
Cell Culture and Immunofluorescence—After incubation with EcoRI
or aphidicolin, extracts were diluted, fixed, and layered on a sucrose
cushion, and nuclei were pelleted onto coverslips as described (30, 31).
Indirect immunofluorescence was performed using goat anti-mouse IgG
conjugated to Alexa 568 (Molecular Probes, Inc.) and goat anti-rabbit
IgG conjugated to Alexa 488 for anti-BM28 and anti-phospho-Ser92
antibodies, respectively. Chromatin was stained with Hoechst 33258 to
visualize the DNA. Samples were viewed on a Zeiss Axioplan fluores-
cence microscope and imaged with a SpotRT CCD camera (Diagnostic
Instruments) at identical magnifications and exposure times.
HeLa cells were treated with -irradiation, UV light, or hydroxyurea
as indicated. Cells were processed 2 h after treatment with -irradia-
tion or UV or 24 h after the addition of hydroxyurea to the culture. For
localized UV damage, cells were overlaid with a 3-m Isopore polycar-
bonate filter (Millipore) prior to irradiation with 100 J/m2 UV as de-
scribed (32) and allowed to recover for 90 min prior to immunostaining.
For immunoblotting, whole cell extracts were prepared and subjected to
SDS-PAGE. For indirect immunofluorescence, cells were grown on poly-
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D-lysine-coated coverslips. After treatment, cells were fixed with 3%
paraformaldehyde in phosphate-buffered saline for 30 min, permeabi-
lized with 1% Triton X-100 in phosphate-buffered saline, and processed
for microscopy. Mouse anti-BM28 monoclonal and rabbit anti-phospho-
Ser108 polyclonal antibodies were used as primary antibodies, and ei-
ther goat anti-mouse IgG conjugated to Alexa 568 or goat anti-rabbit
IgG conjugated to Alexa 488 was used as the secondary antibody at
1:250 dilution. TO-PRO-3 iodide (Molecular Probes, Inc.) or Hoechst
33258 was used to detect nuclear DNA. The coverslips were washed,
mounted onto glass slides, and viewed with a Leica SP confocal micro-
scope or a Zeiss Axioplan fluorescence microscope.
RESULTS
Cloning of a Full-length Xenopus Homolog of ATM—To study
the role of ATM in checkpoint responses in Xenopus egg ex-
tracts, we isolated a cDNA encoding a full-length homolog of
Xenopus ATM (Xatm). A fragment containing the C-terminal
half of Xatm was described previously (33). To identify the
N-terminal region of Xatm, we cloned a 4.8-kb cDNA from a
Xenopus oocyte Marathon cDNA library by 5-rapid amplifica-
tion of cDNA ends. Next, using two primers for the predicted
extreme 5- and 3-ends of Xatm, we amplified a 9.2-kb frag-
ment from this library. Upon DNA sequencing of this fragment,
we identified an open reading frame of 3061 amino acids that
encodes the full-length Xatm protein (Fig. 1A). An alignment of
the N-terminal half of Xatm with human ATM is shown in
Supplemental Fig. S1. The predicted amino acid sequence of
full-length Xatm shares 64% identity with human ATM. The
previously identified kinase domain of Xatm (residues 2676–
2981) is 88% identical between the two species, and the N-
terminal regulatory domain (residues 1–2676) that has now
been fully defined in this study is 61% identical to the corre-
sponding region of human ATM.
Xatm Undergoes Activation in Checkpoint-induced Ex-
tracts—Human ATM undergoes activation in response to dou-
ble-stranded DNA breaks (see Ref. 34). To investigate the reg-
ulation of Xatm, we first examined the effect of a defined DNA
template with double-stranded DNA ends on Xatm in egg ex-
tracts. For this experiment, we utilized annealed oligomers
consisting of (dA)70 and (dT)70. This template ((dA)70-(dT)70)
can induce both DNA damage and DNA replication checkpoint
responses effectively in egg extracts (17, 21). We incubated egg
extracts with either no DNA or (dA)70-(dT)70, immunoprecipi-
tated Xatm with anti-Xatm antibodies, and then assayed its
kinase activity with PHAS-I as the substrate. As shown in Fig.
1B, the activity of Xatm from extracts containing (dA)70-(dT)70
FIG. 1. Xatm undergoes activation during checkpoint responses in egg extracts. A, diagram of full-length Xatm. The sequence of
full-length Xatm contains 3061 amino acids. The phosphoinositide 3-kinase (PI3 kinase) domain and the region used for antibody production (amino
acids 634–878) are denoted. B, Xatm-associated kinase activity. Interphase extracts containing no DNA (lane 2), (dA)70-(dT)70 (pA-pT) (lanes 1 and
3), or (dA)70-(dT)70 plus caffeine (lane 4) were incubated for 100 min and immunoprecipitated (IP) with control IgG (lane 1) or anti-Xatm antibodies
(lanes 2–4). The immunoprecipitates were incubated with PHAS-I as substrate in the presence of [32P]ATP. After SDS-PAGE, PHAS-I was
visualized by Coomassie Brilliant Blue (CBB) staining (lower panel). Incorporation of 32P was detected with a PhosphorImager (upper panel). C,
sensitivity of Xatm-associated kinase activity to caffeine. Kinase assays were performed by incubating control IgG (lane 1) or anti-Xatm (lanes 2–6)
immunoprecipitates from extracts containing no DNA (lane 2) or (dA)70-(dT)70 (lanes 1 and 3–6) with PHAS-I and 0–5 mM caffeine as indicated.
PHAS-I was stained with Coomassie Blue (lower panel), and incorporation of 32P was detected with a PhosphorImager (upper panel). D, sensitivity
of Xatm kinase activity to wortmannin. Anti-Xatm immunoprecipitates from extracts containing (dA)70-(dT)70 were incubated with PHAS-I and
0–10 M wortmannin. PHAS-I was stained with Coomassie Blue (lower panel), and incorporation of 32P was detected with a PhosphorImager
(upper panel). E, extracts incubated for 100 min with 3000 sperm nuclei/l alone (lanes 1 and 4), sperm nuclei plus EcoRI (lanes 2 and 5), or sperm
nuclei plus aphidicolin (APH) (lanes 3 and 6). Nuclear fractions were isolated and extracted with 0.3 M NaCl. The salt eluates were immunopre-
cipitated with control IgG (lanes 1–3) or anti-Xatm antibodies (lanes 4–6). The immunoprecipitates were incubated with PHAS-I in the presence
of [32P]ATP. PHAS-I was stained with Coomassie Blue (lower panel), and incorporation of 32P was detected with a PhosphorImager (middle panel).
The immunoprecipitates were immunoblotted with anti-Xatm antibodies (upper panel).
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was much higher than from extracts lacking DNA. Immuno-
precipitates with control IgG contained negligible kinase
activity.
Caffeine is a well documented inhibitor of phosphoinositide
kinase-related kinases such as ATM and ATR (4). To examine
whether caffeine affects the activation of Xatm, we immuno-
precipitated Xatm from extracts treated with (dA)70-(dT)70 in
the absence or presence of caffeine and then assayed its kinase
activity in the absence of caffeine. Interestingly, we found that
Xatm underwent activation in both the absence and presence of
caffeine (Fig. 1B). To confirm that Xatm is indeed sensitive to
caffeine, we assayed its kinase activity in the presence of var-
ious concentrations of this compound. We observed that the
kinase activity of the activated form of Xatm was totally sup-
pressed when caffeine was present at a concentration of 0.5 mM
or higher in the kinase assay incubation (Fig. 1C). We also
found that Xatm was completely inhibited by 1 M wortmannin
(Fig. 1D), as is the case for human ATM (35). Overall, these
results indicate that Xatm, like human ATM, is sensitive to
caffeine and wortmannin. However, the process leading to the
activation of Xatm can still occur in the presence of caffeine. It
has recently been proposed that the activation of human ATM
involves intermolecular autophosphorylation of inactive ATM
dimers (34). One possibility is that the autophosphorylation
activity of ATM is less sensitive to caffeine. Another scenario is
that the activation of ATM can occur without autophosphoryl-
ation under some circumstances. Finally, since we need to
assay activated Xatm in the absence of caffeine, it is possible
that there is some caffeine-insensitive step upstream of auto-
phosphorylation that is involved in the activation of ATM.
Next, we examined the regulation of Xatm in response to
lesions in chromosomal DNA. For this purpose, we added de-
membranated sperm chromatin to egg extracts to initiate the
formation of reconstituted nuclei. We introduced double-
stranded DNA breaks into the chromosomal DNA by including
the restriction endonuclease EcoRI in the extracts (19). More-
over, we induced the formation of stalled replication forks in
the chromatin by adding the DNA polymerase inhibitor aphidi-
colin. After 100 min, we isolated nuclear fractions from the
incubations, extracted nuclear proteins with 0.3 M NaCl, and
then immunoprecipitated the salt eluates with control or anti-
Xatm antibodies. We observed that the activity of Xatm for
PHAS-I increased in response to treatment with either EcoRI
or aphidicolin (Fig. 1E). Similar amounts of Xatm protein were
immunoprecipitated under all conditions. These results dem-
onstrate that both double-stranded DNA breaks and replica-
tion blocks can elicit the activation of Xatm in egg extracts.
Xatm Interacts Specifically with Xmcm2—The identification
of ATM-interacting proteins could help to elucidate upstream
and downstream regulators of ATM-dependent checkpoint re-
sponses. We searched for Xatm-interacting proteins by immu-
noprecipitating Xatm from Xenopus egg extracts with anti-
Xatm antibodies and silver staining the immunoprecipitates
(Fig. 2A). Our interest was attracted by a band at 120 kDa
because 32P labeling experiments indicated that this protein
underwent cell cycle-regulated and checkpoint-dependent
phosphorylation (Fig. 2B). In particular, the 120-kDa band was
significantly phosphorylated in interphase egg extracts. This
phosphorylation increased in both M phase extracts and inter-
phase extracts containing (dA)70-(dT)70. The elevated phospho-
FIG. 2. Xatm interacts specifically with Xmcm2. A, interphase egg extracts containing (dA)70-(dT)70 were immunoprecipitated (IP) with
control IgG (lane 2) or anti-Xatm antibodies (lane 3). The immunoprecipitates were subjected to SDS-PAGE and silver staining. One band at 120
kDa (marked with the arrowhead in the lower panel) was shown to be Xmcm2 by mass spectrometry (see “Experimental Procedures”). The upper
panel depicts the area of the gel containing Xatm. Lane 1 shows molecular mass marker proteins. B, interphase (I) extracts (lane 1), M phase (M)
extracts (lane 2), and interphase extracts containing either (dA)70-(dT)70 (pA-pT) (lane 3) or (dA)70-(dT)70 plus caffeine (lane 4) were incubated in
the presence of [32P]orthophosphate and immunoprecipitated with anti-Xatm antibodies. The immunoprecipitates were subjected to SDS-PAGE.
Xatm and Xmcm2 were visualized by silver staining. Incorporation of 32P into Xatm or Xmcm2 was detected with a PhosphorImager. C, interphase
extracts containing no DNA (lane 2) or (dA)70-(dT)70 (lanes 1 and 3) were immunoprecipitated with control IgG (lane 1) or anti-Xatm antibodies
(lanes 2 and 3). Immunoprecipitates were immunoblotted with anti-Xmcm2 and anti-Xmcm4 antibodies. D, extracts containing (dA)70-(dT)70 were
immunoprecipitated with control IgG (lane 1) or anti-Xmcm2 antibodies (lane 2). Immunoprecipitates were immunoblotted with anti-Xatm
antibodies.
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rylation in the presence of (dA)70-(dT)70 was reversed by caf-
feine. By comparison, Xatm displayed similar phosphorylation
during interphase and M phase, but its phosphorylation also
increased in interphase extracts containing (dA)70-(dT)70. This
phosphorylation was likewise prevented by the addition of caf-
feine. Mass spectrometric analysis of a large-scale anti-Xatm
immunoprecipitate from interphase egg extracts, which was
stained with Coomassie Blue in this case, indicated that the
120-kDa band corresponds to Xmcm2 (see “Experimental
Procedures”).
To evaluate the specificity of the interaction between Xatm
and Xmcm2, we carried out reciprocal immunoprecipitation
experiments. First, we immunoprecipitated Xatm from inter-
phase egg extracts either lacking or containing (dA)70-(dT)70
and then performed immunoblotting with anti-Xmcm2 anti-
bodies. We observed that Xmcm2 could be found in similar
amounts in the anti-Xatm immunoprecipitates from extracts
that had been incubated in the absence or presence of (dA)70-
(dT)70 (Fig. 2C). We also detected Xmcm4 (Fig. 2C) and Xmcm7
(data not shown) in these immunoprecipitates by immunoblot-
ting, suggesting that the entire MCM complex was isolated
with the anti-Xatm antibodies. Furthermore, we also detected
Xatm in anti-Xmcm2 immunoprecipitates by immunoblotting
with anti-Xatm antibodies (Fig. 2D). These findings indicate
that Xatm and Xmcm2 form a specific complex in egg extracts.
Identification of a Phosphorylation Site on Xmcm2 for
Xatm—Because kinases often form complexes with their sub-
strates, we asked whether Xmcm2 could serve as a substrate
FIG. 3. ATM and ATR phosphorylate Xmcm2 at Ser92. A, GST-Xmcm2 was incubated in the presence of [32P]ATP with no immunoprecipi-
tates (lane 1) or either control immunoprecipitates (lane 2) or anti-Xatm immunoprecipitates (IP) (lane 3) from extracts containing (dA)70-(dT)70.
The samples were subjected to SDS-PAGE. GST-Xmcm2 protein was visualized by Coomassie Brilliant Blue (CBB) staining (lower panel).
Incorporation of 32P was detected with a PhosphorImager (upper panel). B, shown is a diagram of SQ/TQ motifs in Xmcm2. C, GST-Xmcm2-(62–
122) (lanes 1 and 2), GST-Xmcm2-(297–357) (lanes 3 and 4), GST-Xmcm2-(485–545) (lanes 5 and 6), and GST-Xmcm2-(757–817) (lanes 7 and 8)
were incubated with [32P]ATP and either control IgG (lanes 1, 3, 5, and 7) or anti-Xatm (lanes 2, 4, 6, and 8) immunoprecipitates from extracts
containing (dA)70-(dT)70. After SDS-PAGE, GST-tagged fragments were visualized by Coomassie Blue staining (lower panel). Incorporation of
32P
into these fragments was detected with a PhosphorImager (upper panel).D, GST-Xmcm2-(62–122) (lanes 1 and 2) and GST-Xmcm2-(62–122)(S92A)
(lanes 3 and 4) were incubated in the presence of [32P]ATP with control immunoprecipitates (lanes 1 and 3) or anti-Xatm immunoprecipitates from
extracts containing (dA)70-(dT)70 (lanes 2 and 4). The samples were subjected to SDS-PAGE. GST-Xmcm2 fragments were stained with Coomassie
Blue (lower panel). Incorporation of 32P was detected with a PhosphorImager (upper panel). E and F, human ATM and ATR phosphorylated Xmcm2
at Ser92. Wild-type (WT) or kinase-inactive (KD) FLAG-ATM and FLAG-ATR were isolated from 293T cells as described under “Experimental
Procedures.” For E, PHAS-I (lanes 1 and 2), GST-Xmcm2-(62–122) (lanes 3 and 4), and GST-Xmcm2-(62–122)(S92A) (lanes 5 and 6) were incubated
in the presence of [32P]ATP with kinase-inactive FLAG-ATM (lanes 1, 3, and 5) and wild-type FLAG-ATM (lanes 2, 4, and 6). For F, kinase-inactive
FLAG-ATR (lanes 1, 3, and 5) and wild-type FLAG-ATR (lanes 2, 4, and 6) were used in the kinase reactions. The samples were subjected to
SDS-PAGE. PHAS-I and GST-tagged Xmcm2 fragments were visualized by Coomassie Blue staining (lower panel), and incorporation of 32P was
detected with a PhosphorImager (upper panel).
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for Xatm. As shown in Fig. 3A, full-length GST-Xmcm2 under-
went efficient phosphorylation upon incubation with [32P]ATP
and anti-Xatm immunoprecipitates from (dA)70-(dT)70-contain-
ing extracts, but not with control immunoprecipitates from
such extracts. It is known that ATM, ATR, and the DNA-de-
pendent protein kinase display a preference to phosphorylate
SQ or TQ motifs in their substrates (36). Xmcm2 contains three
SQ motifs (Ser92, Ser327, and Ser515) and one TQ motif (Thr787)
(Fig. 3B). To assess whether Xatm could phosphorylate these
sites, we prepared bacterially expressed GST fusion peptides
containing amino acids 62–122, 297–357, 485–545, and 757–
817 of Xmcm2. Each GST peptide was designed to contain one
SQ/TQ motif. We observed that GST-Xmcm2-(62–122) served
as an excellent substrate for immunoprecipitated Xatm (Fig.
3C). By contrast, the other three GST-Xmcm2 peptides did not
become phosphorylated in this assay. To evaluate whether
Ser92 is the phosphorylated site in GST-Xmcm2-(62–122), we
prepared a version of GST-Xmcm2-(62–122) in which this res-
idue was changed to alanine. As shown in Fig. 3D, GST-
Xmcm2-(62–122)(S92A) could not serve as a substrate for
Xatm.
To characterize these observations further, we asked
whether recombinant ATM could also phosphorylate Xmcm2.
We were unable to produce full-length His6-Xatm in baculovi-
rus-infected insect cells (data not shown). Therefore, we used
recombinant human FLAG-tagged ATM that had been ex-
pressed in human 293T cells for these experiments. We found
that wild-type FLAG-ATM could phosphorylate the GST-
Xmcm2-(62–122) substrate as efficiently as PHAS-I (Fig. 3E).
As a control, we showed that kinase-inactive FLAG-ATM could
not phosphorylate either GST-Xmcm2-(62–122) or PHAS-I in
these assays. Consistent with the results described for immu-
noprecipitated Xatm, human FLAG-ATM did not phosphoryl-
ate the GST-Xmcm2-(62–122)(S92A) peptide.
Because ATM and ATR share related substrate specificities,
we also asked whether Ser92 of Xmcm2 could serve as a sub-
strate for ATR. To test this possibility, we performed kinase
assays using wild-type and kinase-inactive recombinant hu-
man FLAG-ATR, both of which were also expressed in 293T
cells. As shown in Fig. 3F, wild-type FLAG-ATR, but not ki-
nase-inactive FLAG-ATR, also phosphorylated GST-Xmcm2-
(62–122) efficiently. The S92A mutant of this peptide was not
phosphorylated by FLAG-ATR in these assays.
Phosphorylation of Xmcm2 at Ser92 Is Checkpoint-regulated—
Next, we examined whether Ser92 of Xmcm2 undergoes phospho-
rylation in egg extracts. As one means to address this issue, we
incubatedGST-Xmcm2-(62–122) andGST-Xmcm2-(62–122)(S92A)
in egg extracts containing [32P]orthophosphate in the presence and
absence of (dA)70-(dT)70. As depicted in Fig. 4A, GST-Xmcm2-(62–
122) became efficiently labeled with 32P in the presence of (dA)70-
(dT)70, but not in its absence. There was no labeling of the S92A
mutant polypeptide in these experiments.
To establish directly that Ser92 undergoes phosphorylation
in egg extracts, we prepared antibodies against a synthetic
peptide from a region of Xmcm2 that contains phosphorylated
Ser92 (anti-phospho-Ser92 antibodies). The anti-phospho-Ser92
antibodies reacted well with GST-Xmcm2-(62–122) in extracts
that had been incubated in the presence of (dA)70-(dT)70, but
not in its absence (Fig. 4B). The anti-phospho-Ser92 antibodies
did not recognize the GST-Xmcm2-(62–122)(S92A) mutant
polypeptide under any conditions (Fig. 4B). We also examined
the endogenous Xmcm2 protein in similar experiments. The
anti-phospho-Ser92 antibodies could likewise detect phospho-
rylation of endogenous Xmcm2 in egg extracts in response to
(dA)70-(dT)70 (Fig. 4C). This phosphorylation was substantially
reduced upon the addition of caffeine.
To examine the effect of lesions in chromosomal DNA on the
phosphorylation of Xmcm2 at Ser92, we introduced double-
stranded breaks or caused the formation of stalled replication
forks by adding EcoRI or aphidicolin, respectively, to egg ex-
tracts containing sperm chromatin. After 100 min of incuba-
tion, we isolated chromatin fractions from the extracts and
performed immunoblotting with antibodies against Xmcm2,
phospho-Ser92 of Xmcm2, and Xorc2 (to follow recovery of chro-
matin) (Fig. 4D). We observed that Xmcm2 could be found in
elevated amounts on both EcoRI-damaged and aphidicolin-
treated chromatin. Xmcm2 that had associated with chromatin
in extracts treated with EcoRI or aphidicolin reacted strongly
with the anti-phospho-Ser92 antibodies. By contrast, Xmcm2
that remained in nuclear soluble fractions from these extracts
was only weakly phosphorylated at Ser92. We observed that
Ser92 of Xmcm2 likewise was phosphorylated on chromatin
containing UV damage, which also creates DNA replication
blocks (data not shown). Finally, chromatin-bound Xmcm2
from control extracts lacking EcoRI or aphidicolin did not react
with the anti-phospho-Ser92 antibodies.
We also examined time courses for the phosphorylation of
Xmcm2 at Ser92 under the various conditions described above
(Fig. 4E). In control egg extracts, the binding of Xmcm2 to
chromatin typically began in 5–10 min, peaked at 60–80 min,
and then declined by 120 min as DNA replication approached
completion (data not shown). In extracts treated with EcoRI
and aphidicolin, Xmcm2 bound in elevated amounts to chroma-
tin, and the binding persisted until at least 150 min. In both
cases, the phosphorylation of Xmcm2 at Ser92 commenced at
40 min, which coincides with the timing that DNA replication
would normally undergo initiation in untreated extracts.
To characterize further the phosphorylation of Xmcm2 at
Ser92, we performed indirect immunofluorescence studies. For
this purpose, we used anti-Xmcm2 and anti-phospho-Ser92 an-
tibodies for immunostaining nuclei that were isolated from egg
extracts (Fig. 4F). By this procedure, we could readily detect
the Xmcm2 protein in nuclei from control extracts as well as in
nuclei from extracts that were treated with EcoRI or aphidico-
lin. By contrast, the anti-phospho-Ser92 antibodies reacted only
with EcoRI- and aphidicolin-treated nuclei. In all cases, the
anti-Xmcm2 antibodies yielded a diffuse staining pattern that
largely coincided with the DNA, consistent with previous find-
ings in various organisms. By contrast, the staining with the
anti-phospho-Ser92 antibodies in nuclei containing incom-
pletely replicated or damaged DNA was more punctate. Taken
together, these experiments indicate that the anti-phospho-
Ser92 antibodies are useful for detecting the checkpoint-de-
pendent phosphorylation of Mcm2 by both immunoblotting and
indirect immunofluorescence.
Human MCM2 Undergoes Phosphorylation at Ser108 in Re-
sponse to Genotoxic Stress—To investigate whether the phos-
phorylation of MCM2 during checkpoint responses is conserved
in mammalian cells, we examined HeLa cells that were sub-
jected to a variety of genotoxic stresses. The amino acid se-
quence around the S92Q motif of Xmcm2 is well conserved in
both human and mouse MCM2 (Fig. 5D). Therefore, it seemed
likely that the anti-phospho-Ser92 antibodies directed against
phosphorylated Xmcm2 could detect the phosphorylation of the
corresponding serine (Ser108) in human MCM2. We exposed
exponentially growing HeLa cells to -irradiation (2.5–10
gray), ultraviolet light (50–200 J/m2), or hydroxyurea (0.5–2
mM). After 2 h in the cases of the -irradiation and UV treat-
ments or after 24 h for the hydroxyurea treatment, we pre-
pared lysates from the cells and performed immunoblotting
with anti-MCM2 protein and anti-phosphorylated MCM2 anti-
bodies. We found that human MCM2 was well phosphorylated
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FIG. 4. Phosphorylation of Xmcm2 at Ser92 is induced by double-stranded DNA breaks and replication blocks. A, phosphorylation of
Xmcm2 at Ser92 was induced by the addition of (dA)70-(dT)70 to egg extracts. GST-Xmcm2-(62–122) and GST-Xmcm2-(62–122)(S92A) were
incubated in egg extracts containing [32P]orthophosphate in the absence (lanes 1 and 3) or presence (lanes 2 and 4) of (dA)70-(dT)70 (pA-pT).
GST-Xmcm2 fragments were re-isolated with glutathione-agarose beads, subjected to SDS-PAGE, and stained with Coomassie Brilliant Blue
(CBB) (lower panel). Incorporation of 32P was detected with a PhosphorImager (upper panel). B, shown is the specificity of anti-phospho-Ser92
antibodies. Interphase extracts containing no DNA (lanes 1 and 3) or (dA)70-(dT)70 (lanes 2 and 4) were incubated with GST-Xmcm2-(62–122) (lanes
1 and 2) or GST-Xmcm2-(62–122)(S92A) (lanes 3 and 4). The GST-tagged Xmcm2 fragments were re-isolated with glutathione-agarose and
subjected to SDS-PAGE. The fragments were probed by immunoblotting with anti-phospho-Ser92 (P-S92) (upper panel) or anti-GST (lower panel)
antibodies. C, phosphorylation of endogenous Xmcm2 at Ser92 was induced by (dA)70-(dT)70. Interphase (I) extracts (lane 1), M phase (M) extracts
(lane 2), and interphase extracts containing (dA)70-(dT)70 (lane 3) or (dA)70-(dT)70 plus caffeine (lane 4) were incubated for 100 min and
subsequently subjected to SDS-PAGE. Xmcm2 was probed by immunoblotting with anti-Xmcm2 (upper panel) and anti-phospho-Ser92 (lower panel)
antibodies. D, extracts were incubated for 100 min with 3000 sperm nuclei/l alone (lanes 1 and 4), sperm nuclei plus EcoRI (lanes 2 and 5), or
sperm nuclei plus aphidicolin (APH) (lanes 3 and 6). Chromatin fractions (lanes 1–3) and nuclear soluble fractions (lanes 4–6) were isolated and
immunoblotted with anti-Xmcm2 (upper panel), anti-phospho-Ser92 (middle panel), and anti-Xorc2 (lower panel) antibodies. Xorc2 served as a
loading control for the chromatin fractions. E, chromatin fractions were isolated at the times shown from extracts containing EcoRI or aphidicolin
and probed by immunoblotting with anti-Xmcm2, anti-phospho-Ser92, and anti-Xorc2 antibodies as indicated. F, shown is the immunostaining of
reconstituted sperm nuclei with anti-Xmcm2 and anti-phospho-Ser92 antibodies. Sperm nuclei were incubated in mock-treated extracts (upper row)
or in extracts treated with either EcoRI (middle row) or aphidicolin (lower row). Nuclei were stained with anti-Xmcm2 and anti-phospho-Ser92
antibodies as indicated. DNA was visualized with Hoechst 33258.
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at Ser108 in response to -irradiation, UV light, and hydroxyu-
rea at all doses tested (Fig. 5A). For -irradiation treatment,
phosphorylation was maximal at dose of 10 gray. A concentra-
tion of 2 mM hydroxyurea elicited the highest phosphorylation
of Ser108, and the level of phosphorylation of this residue was
similar at doses of UV light ranging from 50 to 200 J/m2. By
contrast, there was no phosphorylation of Ser108 in mock-
treated cells that had not been exposed to genotoxic stress.
We also examined the subcellular localization of MCM2 and
phosphorylated MCM2 in HeLa cells following genotoxic stress.
After treatment with -irradiation, hydroxyurea, or UV light,
we visualized MCM2 and Ser108-phosphorylated MCM2 by in-
direct immunofluorescence (Fig. 5B). Consistent with the im-
munoblotting analysis, phosphorylated MCM2 could be de-
tected in cells treated with -irradiation, hydroxyurea, and UV
light, but not in mock-treated cells. As was the case in Xenopus
sperm nuclei, the antibodies against phosphorylated MCM2
yielded a punctate staining pattern. To pursue these observa-
tions further, we generated localized UV damage in HeLa cell
nuclei by overlaying the cells with a 3-m Isopore polycarbon-
ate filter prior to irradiation. We observed that this treatment
resulted in a highly punctate staining pattern with the anti-
phospho-Ser108 antibodies (Fig. 5C). Interestingly, there was
also some accumulation of the MCM2 protein in these regions
as well. Taken together, these findings indicate that phospho-
rylation of a conserved serine in MCM2 (e.g. Ser92 in Xenopus
and Ser108 in humans) is a reliable marker for checkpoint
activation in vertebrate cells.
Phosphorylation of Xmcm2 at Ser92 Is Dependent on Xatm
and Xatr in Egg Extracts—Next, we examined the involvement
of Xatm and Xatr in the phosphorylation of Xmcm2 at Ser92 in
egg extracts. For this purpose, we removed Xatm, Xatr, or both
Xatm and Xatr from the extracts by immunodepletion (Fig. 6A).
First, we examined the phosphorylation of Xmcm2 at Ser92 by
32P labeling. GST-Xmcm2-(62–122) was incubated in the vari-
ous depleted extracts containing [32P]orthophosphate in the
presence of (dA)70-(dT)70 (Fig. 6B). The phosphorylation of
Ser92 in Xatm-depleted extracts was reduced to 50% in com-
parison with that in mock-depleted extracts. Furthermore, the
phosphorylation of Ser92 in extracts lacking both Xatm and
Xatr was reduced to 20% of the mock-depleted value. We
observed a similarly reduced level of phosphorylation of Ser92
in caffeine-treated extracts. These results suggest that Xatm
plays a more prominent role than Xatr in phosphorylation of
Ser92 in response to (dA)70-(dT)70.
We also used anti-phospho-Ser92 antibodies to assess the
involvement of Xatm and Xatr in the checkpoint-dependent
phosphorylation of Mcm2 (Fig. 6C). In addition to the response
to (dA)70-(dT)70, we also examined how removal of Xatm and
Xatr affects the responses to treatment with EcoRI or aphidi-
colin. For extracts treated with (dA)70-(dT)70, the removal of
Xatm led to a greater reduction in the staining of Xmcm2 with
the anti-phospho-Ser92 antibodies than removal of Xatr, con-
sistent with the 32P labeling studies described above. In the
case of EcoRI-treated extracts, the removal of Xatm likewise
had a greater effect, and depletion of both Xatm and Xatr led to
a reduction of Ser92 phosphorylation similar to that observed
following treatment with caffeine. Finally, in aphidicolin-
treated extracts, depletion of Xatr caused a greater reduction of
Ser92 phosphorylation, but removal of Xatm also had a signif-
icant impact. Furthermore, absence of both Xatm and Xatr
resulted in a level of Ser92 phosphorylation comparable with
that in caffeine-treated extracts. Taken together, these results
indicate that both Xatm and Xatr participate in the checkpoint-
dependent phosphorylation of Xmcm2 at Ser92, but that the
relative contribution of either kinase depends on the check-
point-triggering signal.
Xatm and Xatr Cooperatively Inhibit DNA Replication in
Response to Double-stranded DNA Breaks—To assess the po-
tential physiological role of the checkpoint-dependent phospho-
rylation of Xmcm2, we examined the effects of double-stranded
DNA breaks on cell cycle progression and DNA replication in
egg extracts. As reported previously (19), the restriction endo-
nuclease EcoRI can be used to introduce double-stranded DNA
breaks into sperm chromatin in Xenopus egg extracts. As
shown in Fig. 7A, the entry into mitosis occurred after 90–120
FIG. 5. Phosphorylation of human MCM2 at Ser108 by DNA
damage and subcellular localization of MCM2. A, HeLa cells were
mock-treated or treated as indicated with -irradiation (IR), hydroxyu-
rea (HU), or ultraviolet light (UV). Cell extracts were prepared 2 h after
treatment with -irradiation or UV light or 24 h after the addition of
hydroxyurea, subjected to SDS-PAGE, and immunoblotted with anti-
MCM2 (BM28) antibodies and anti-phospho-Ser108 (P-S108) antibodies.
B, shown is the subcellular localization of MCM2 and phosphorylated
MCM2 in HeLa cells. Cells were fixed after treatment with -irradia-
tion (5 gray), hydroxyurea (1 mM), or UV light (100 J/m2); immuno-
stained with anti-MCM2 and anti-phospho-Ser108 antibodies; and
viewed under a confocal microscope. Nuclei were visualized by staining
with TO-PRO-3 iodide. C, HeLa cells were overlaid with a 3-m Isopore
polycarbonate filter, irradiated with 100 J/m2 UV light, and allowed to
recover for 90 min. Cells were stained with anti-MCM2 antibodies,
anti-phospho-Ser108 antibodies, and Hoechst DNA dye before visualiza-
tion by fluorescence microscopy. D, shown is the alignment of residues
84–98 from XenopusMcm2 with the corresponding segments of human
and mouse MCM2.
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min in control egg extracts. By contrast, the presence of EcoRI-
damaged chromatin elicited a prolonged arrest in interphase.
This arrest could be ablated completely by the addition of
caffeine. Treatment with EcoRI also caused a major reduction
in DNA replication (Fig. 7B), consistent with the results of
Kobayashi et al. (19). The small amount of residual DNA syn-
thesis in EcoRI-treated extracts in comparison with aphidico-
lin-treated extracts appears to be due to DNA repair because
this incorporation was not sensitive to geminin (Fig. 7C), which
blocks initiation of chromosomal DNA replication. The EcoRI-
induced inhibition of replication was almost completely re-
versed by the addition of caffeine.
To assess the roles of Xatm and Xatr in the inhibition of
replication in response to double-stranded DNA breaks, we
removed Xatm, Xatr, or both Xatm and Xatr from egg extracts
by immunodepletion. As shown in Fig. 7 (D and E), the removal
of either Xatm or Xatr alone resulted in significant restoration
of DNA replication in EcoRI-treated extracts (to 20–30% of
the level in mock-depleted extracts lacking EcoRI). Further-
more, depletion of both Xatm and Xatr resulted in a level of
DNA replication that was 70% of the normal level. Therefore,
it appears that both Xatm and Xatr act cooperatively to inhibit
DNA replication in response to double-stranded DNA breaks.
In principle, Xatm and Xatr could directly regulate one or
more targets that are necessary for DNA replication. Another
(although not mutually exclusive) possibility is that Xatm and
Xatr could initiate this response through activating down-
stream checkpoint effector kinases (e.g. Xchk2 and Xchk1, re-
spectively). However, we observed that immunodepletion of
Xchk2, Xchk1, or both Xchk2 and Xchk1 from egg extracts had
no effect on the ability of EcoRI to cause inhibition of chromo-
somal DNA replication in egg extracts (Fig. 7G). This observa-
tion favors the possibility that Xatm and Xatr exert their in-
hibitory effects directly or perhaps act through distinct
downstream effectors.
To assess the role of Ser92 phosphorylation on Xmcm2 by
Xatm and Xatr, we added various non-phosphorylatable mu-
tants of baculovirus-expressed Xmcm2 to egg extracts to ob-
serve potential dominant-negative effects. We chose this ap-
proach because immunodepletion of Xmcm2 from egg extracts
results in removal of the entire MCM complex, and functional
reconstitution of any vertebrate MCM complex that could be
used for add-back experiments has not been reported at this
time. We mutated Ser92 to either alanine or aspartic acid (to
potentially mimic constitutive phosphorylation at this site). We
introduced these mutations into both Xmcm2 tagged at the
C-terminal end with GST and His6 (Xmcm2-GST-His6) and
Xmcm2 tagged at the N-terminal end with His6 (His6-Xmcm2).
The endogenous MCM complex in egg extracts appears to be
dynamic in that we could observe association of exogenously
added, recombinant Xmcm2 with endogenous MCM subunits.
For example, as shown in Fig. 8A, we could demonstrate bind-
ing of endogenous Xmcm4 and Xmcm7 to the wild-type, S92A,
and S92D versions of exogenously added Xmcm2-GST-His6.
Next, we examined whether the addition of the Ser92 mu-
tants of Xmcm2 to egg extracts could have a functional conse-
quence. Since we could express His6-Xmcm2 in higher amounts
than Xmcm2-GST-His6 in insect cells, we pursued using His6-
tagged proteins for these experiments. We added wild-type
His6-Xmcm2, His6-Xmcm2(S92A), or His6-Xmcm2(S92D) to egg
extracts at a level 6-fold over that of endogenous Xmcm2. We
found that all three recombinant proteins could associate with
chromatin to equal extents (Fig. 8B). This observation is con-
sistent with the finding that recombinant Xmcm2 can associate
with other MCM subunits (e.g. Xmcm4 and Xmcm7). The re-
combinant Xmcm2 proteins on chromatin could be distin-
guished on the basis of a slightly slower electrophoretic mobil-
ity due to the presence of the His6 tag. However, none of these
FIG. 6. Xatm and Xatr phosphorylate Xmcm2 at Ser92. A, shown is
the immunodepletion of Xatm (Xatm), Xatr (Xatr), or both Xatm and
Xatr. Extracts were mock-treated (mock immunodepletion with control
IgG) (lane 1) or treated with anti-Xatm antibodies (lane 2), anti-Xatr
antibodies (lane 3), or both anti-Xatm and anti-Xatr antibodies (lane 4)
and processed for immunoblotting with anti-Xatm (upper panel) or anti-
Xatr (lower panel) antibodies. Lane 5 depicts untreated extract. B, phos-
phorylation of GST-Xmcm2-(62–122) at Ser92 in the presence of (dA)70-
(dT)70 was dependent on Xatm and Xatr. Untreated extracts (lanes 1, 2,
and 7), mock-depleted extracts (lane 3), Xatm-depleted extracts (lane 4),
Xatr-depleted extracts (lane 5), and Xatm- and Xatr-depleted extracts
(lane 6) were incubated with GST-Xmcm2-(62–122) in the presence of no
DNA (lane 1), (dA)70-(dT)70 (pA-pT) (lanes 2–6), or (dA)70-(dT)70 plus
caffeine (lane 7). All extracts contained [32P]orthophosphate. GST-
Xmcm2-(62–122) was re-isolated with glutathione-agarose beads, sub-
jected to SDS-PAGE, and visualized by Coomassie Brilliant Blue (CBB)
staining (lower panel). Incorporation of 32P was detected with a Phospho-
rImager (upper panel). C, the indicated extracts in A were incubated in
the presence of no DNA, (dA)70-(dT)70 (upper panels), EcoRI-damaged
sperm chromatin (middle panels), or aphidicolin (APH)-treated chromatin
(lower panels). In addition, the extracts either lacked or contained caffeine
as indicated. Chromatin fractions were isolated from the extracts and
processed for immunoblotting with anti-Xmcm2, anti-phospho-Ser92 (P-
S92), and anti-Xorc2 antibodies as indicated.
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recombinant proteins affected DNA replication in control un-
treated extracts. Moreover, these proteins did not cause any
obvious restoration of DNA replication in EcoRI-treated
extracts.
DISCUSSION
In this study, we have identified Xmcm2 as a protein that
associates specifically with Xatm. We proceeded to show that
Xmcm2 underwent phosphorylation at Ser92 during checkpoint
responses to either damaged or incompletely replicated DNA.
In these cases, phosphorylation of Ser92 involved both Xatm
and Xatr, but to different extents depending on the checkpoint-
triggering signal. Moreover, recombinant human ATM and
ATR both phosphorylated Ser92 very efficiently in cell-free ki-
nase assays. Immunodepletion of both Xatm and Xatr largely
abolished the functioning of the checkpoint mechanism that
blocks chromosomal DNA replication in egg extracts containing
damaged DNA. Taken together, these results indicate that
Xmcm2 is a target of the DNA damage and DNA replication
checkpoint responses in Xenopus egg extracts (Fig. 9). In hu-
man cells, MCM4 also undergoes caffeine-sensitive, checkpoint-
dependent phosphorylation, but a direct role for ATR was not
addressed (37). While this manuscript was in preparation, it
was reported that ATM and ATR phosphorylate mammalian
MCM2 on a site analogous to the one that we have found in
Xmcm2 (38).
FIG. 7. DNA replication is inhibited
by double-stranded DNA breaks in an
Xatm- and Xatr-dependent manner.
A, interphase extracts containing sperm
nuclei (1000/l) were incubated with no
drug (●), caffeine (E), EcoRI (Œ), or EcoRI
plus caffeine (‚) as indicated. Nuclear en-
velope breakdown (NEB) was determined
at the indicated times by microscopy. B,
shown is the DNA replication of sperm
chromatin. Interphase extracts containing
sperm nuclei were incubated for 90 min
with no drug (lane 1), EcoRI (lane 2), or
aphidicolin (APH) (lane 3). Incorporation of
32P from [32P]dATP into chromatin was de-
tected with a PhosphorImager. C, inhibi-
tion of replication by EcoRI was reversed
by caffeine. Extracts were treated with
buffer alone (lanes 1 and 2), geminin (lanes
3 and 4), or caffeine (lanes 5 and 6). Sperm
chromatin was incubated in the extracts in
the absence (lanes 1, 3, and 5) or presence
(lanes 2, 4, and 6) of EcoRI. Incorporation of
32P from [32P]dATP into chromatin was de-
tected with a PhosphorImager.D, shown is
the immunodepletion of Xatm (Xatm),
Xatr (Xatr), or both Xatm and Xatr. Ex-
tracts were treated with control IgG (upper
and lower panels, lane 1), anti-Xatm anti-
bodies (upper panel, lane 2), anti-Xatr an-
tibodies (lower panel, lane 2), or both anti-
Xatm and anti-Xatr antibodies (upper and
lower panels, lane 3) and processed for im-
munoblotting with anti-Xatm (upper
panel) or anti-Xatr (lower panel) antibod-
ies.Lane 4 (upper and lower panels) depicts
untreated extract. E, depletion of both
Xatm and Xatr rescued the replication ar-
rest induced by double-stranded DNA
breaks. Mock-depleted extracts (lanes 1
and 2), Xatm-depleted extracts (lanes 3 and
4), Xatr-depleted extracts (lanes 5 and 6),
or Xatm- and Xatr-depleted extracts (lanes
7 and 8) were incubated in the absence
(lanes 1, 3, 5, and 7) or presence (lanes 2, 4,
6, and 8) of EcoRI. Incorporation of 32P
from [32P]dATP into chromatin was de-
tected with a PhosphorImager. F, shown is
the immunodepletion of Xchk2 (Xchk2),
Xchk1 (Xchk1), or both Xchk2 and Xchk1.
Extracts were treated with control IgG (up-
per and lower panels, lane 1), anti-Xchk2
antibodies (upper panel, lane 2), anti-
Xchk1 antibodies (lower panel, lane 2), or
both anti-Xchk2 and anti-Xchk1 antibodies
(upper and lower panels, lane 3) and pro-
cessed for immunoblotting with anti-Xchk2
(upper panel) or anti-Xchk1 (lower panel)
antibodies. Lane 4 (upper and lower pan-
els) depicts untreated extract. G, the indi-
cated extracts from F were incubated with
sperm nuclei in the absence (lanes 1, 3, 5,
and 7) or the presence (lanes 2, 4, 6, and 8)
of EcoRI and then assayed for DNA
replication.
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TheMCM complex plays a key role in various aspects of DNA
replication (13, 14). This complex is essential for recruiting key
replication proteins such as Cdc45 to prospective sites of rep-
lication. In turn, Cdc45, along with the kinases Cdk2 and Cdc7,
is necessary for the firing of replication origins so that replica-
tion protein A and the replicative DNA polymerases can gain
access to the unwound DNA. It is now widely accepted that the
MCM complex contains a helicase activity that is necessary for
replicative unwinding of the DNA, although incontrovertible
proof may still be lacking. Altogether, it appears that the MCM
complex possesses critical regulatory and catalytic roles in
DNA replication. Therefore, this complex would be a logical
target for regulating various aspects of DNA replication.
A wide variety of observations have indicated that disrup-
tions in the genome inhibit DNA replication. For example, it is
well known that treatment of mammalian cells with ionizing
radiation leads to a diminution of DNA replication during S
phase. One of the characteristics of ATM-deficient cells is that
these cells exhibit “radio-resistant DNA synthesis” following
DNA damage (39). This finding implicates ATM as a critical
regulator of this normal cellular response to DNA damage.
Similarly, in budding yeast, the ATR homolog Mec1 blocks the
firing of late replication origins in cells treated with hydroxyu-
rea (40, 41). This pathway appears to inhibit the kinase Cdc7,
which is involved in the MCM-dependent loading of Cdc45 onto
chromatin in yeast and vertebrates (42, 43).
The checkpoint-dependent inhibition of DNA replication can
be studied effectively in Xenopus egg extracts. The presence of
double-stranded DNA breaks in egg extracts inhibits chromo-
somal DNA replication as well as entry into mitosis (17–19).
Interestingly, aphidicolin, which inhibits DNA polymerase ac-
tivity, also triggers a pathway that blocks utilization of as yet
unfired origins (24, 44). This response is sensitive to the check-
point-overriding compound caffeine. This sensitivity could be
demonstrated by the addition of caffeine to egg extracts con-
taining a concentration of aphidicolin that is sufficient to block
subsequent origin firing, but low enough to allow some DNA
polymerase activity (24). Under such conditions, treatment
with caffeine leads to increased binding of Cdc45 to the DNA
and resumed initiation of nascent strand DNA synthesis at
newly unwound DNA replication forks. Two different groups
have recently extended this observation by demonstrating ex-
plicitly that caffeine inhibits ATR and/or ATM in this process
(45, 46). We have shown in this work that treatment with
aphidicolin led to caffeine-sensitive phosphorylation of Xmcm2
at Ser92. We also found that the suppression of DNA replication
in response to double-stranded DNA breaks depended upon
both Xatm and Xatr. Previous studies had revealed a role only
for Xatm in this pathway (18). Xmcm2 also underwent phos-
phorylation at Ser92 in response to double-stranded DNA
breaks in a manner that depended upon both Xatm and Xatr.
Overall, although the initiating checkpoint signal appears to be
different in both cases (e.g. stalled replication forks versus
double-stranded DNA breaks), phosphorylation of Xmcm2 at
Ser92 is a shared step of these checkpoint pathways.
In principle, phosphorylation of Xmcm2 at Ser92 could have a
number of different functions. For example, this phosphoryla-
tion could impair the firing of replication origins or limit the
helicase activity of MCM complexes at existing replication
forks. Either effect would result in diminished DNA replica-
FIG. 8. Addition of recombinant Xmcm2 with Ser92 mutations
to Xenopus egg extracts. A, recombinant Xmcm2 associated with
other MCM subunits in egg extracts. Control His6-GST, wild-type Xmcm2-
GST-His6 (Xmcm2-GH), Xmcm2(S92D)-GST-His6, and Xmcm2(S92A)-GST-
His6 were incubated in egg extracts and re-isolated with glutathione-agar-
ose beads. The samples were subjected to SDS-PAGE and immunoblotting
with anti-Xmcm4 and anti-Xmcm7 antibodies.B, egg extracts containing no
added protein (lanes 1 and 5), wild-type His6-Xmcm2 (lanes 2 and 6), His6-
Xmcm2(S92D) (lanes 3 and 7), and His6-Xmcm2(S92A) (lanes 4 and 8) were
incubated in the absence (lanes 1–4) or presence (lanes 5–8) of EcoRI.Whole
extracts were immunoblotted with anti-Xmcm2 antibodies (upper panel).
Chromatin fractions were isolated and immunoblotted with anti-Xmcm2
and anti-Xorc2 antibodies (middle two panels). DNA replication was meas-
ured by incorporation of 32P from [32P]dATP (lower panel).
FIG. 9. Model for inhibition of DNA replication and induction
of cell cycle arrest by Xatm and Xatr during checkpoint re-
sponses. See “Discussion” for details.
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tion. To date, we have not been able to obtain any direct
evidence that phosphorylation of Ser92 is necessary for DNA
damage-dependent inhibition of replication, but it is possible
that our methodologies may not be able to detect such an effect.
With this caveat, these observations could mean that phospho-
rylation of Ser92 is not necessary for this inhibition or that
another inhibitory step(s) acts redundantly with this phospho-
rylation. Another possibility is that phosphorylation of Ser92
may help to stabilize the MCM complex on the chromatin for
resumption of DNA replication after repair of checkpoint-in-
ducing lesions. This function may be critical because removal of
the MCM complex during S phase irreversibly inhibits recovery
from a replication arrest (47). Finally, phosphorylation of
Xmcm2 may play some role in the DNA repair process itself.
An interesting property of the MCM complex is that there is
a large excess of this complex compared with the amount of the
origin recognition complex on chromatin (14, 48, 49). In partic-
ular, in Xenopus egg extracts,10–40 MCM complexes appear
to be loaded onto the DNA for each origin recognition complex
particle (12). Only a small fraction of these MCM complexes
becomes activated for origin firing and DNA unwinding. Such
observations illustrate the so-called “MCM paradox,” whereby
the number of MCM complexes on the DNA greatly exceeds the
number of sites for ongoing DNA synthesis. One hypothesis is
that an excess of MCM complexes may be critical for ensuring
that replication origins are suitably spaced in the genome (see
Ref. 12). In addition, a consequence of this apparent surplus is
that the MCM complex would be distributed widely on chro-
matin to respond to any problems or insults in the genome.
Significantly, even modestly reduced MCM function confers
genomic instability in yeast, which raises the possibility that
the MCM complex has a role independent of DNA replication
(50). Further study of how ATM and ATR control the replica-
tion machinery may help to reveal how vertebrate cells main-
tain the integrity of their genomes.
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